These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26974259)

  • 1. Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry.
    Mirón-Rubio M; González-Ramallo V; Estrada-Cuxart O; Sanroma-Mendizábal P; Segado-Soriano A; Mujal-Martínez A; Del Río-Vizoso M; García-Lezcano M; Martín-Blanco N; Florit-Serra L; Gil-Bermejo M
    Future Microbiol; 2016; 11(3):375-90. PubMed ID: 26974259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.
    Pajarón M; Fernández-Miera MF; Allende I; Arnaiz AM; Gutiérrez-Cuadra M; Cobo-Belaustegui M; Armiñanzas C; de Berrazueta JR; Fariñas MC; Sanroma P;
    Eur J Intern Med; 2015 Mar; 26(2):131-6. PubMed ID: 25596808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program.
    Pajarón M; Lisa M; Fernández-Miera MF; Dueñas JC; Allende I; Arnaiz AM; Sanroma-Mendizábal P; De Berrazueta JR; Fariñas MC;
    Hosp Pract (1995); 2017 Dec; 45(5):246-252. PubMed ID: 29090606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.
    Hodgson KA; Huynh J; Ibrahim LF; Sacks B; Golshevsky D; Layley M; Spagnolo M; Raymundo CM; Bryant PA
    Arch Dis Child; 2016 Oct; 101(10):886-93. PubMed ID: 27166221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.
    Barr DA; Semple L; Seaton RA
    Int J Antimicrob Agents; 2012 May; 39(5):407-13. PubMed ID: 22445493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of ertapenem used in hospital-at-home units: data from Spanish Outpatient Parenteral Antimicrobial Therapy Registry.
    Sanroma P; Muñoz P; Mirón-Rubio M; Aguilera A; Estrada O; García D; González-Ramallo VJ; Pajarón M; Sgaramella GA; González CR; Mujal A; Abad A; Solé A; González S; Escalada C; Vitoria I; Gómez MJ; Parra JJ; Sampedro I; Pereda I
    Future Microbiol; 2018 Sep; 13():1363-1373. PubMed ID: 30238769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of outpatient parenteral antimicrobial therapy in acute exacerbation of chronic obstructive pulmonary disease.
    Ponce González MA; Mirón Rubio M; Mujal Martinez A; Estrada Cuxart O; Fiuza Perez D; Salas Reinoso L; Fernández Fabrellas E; Chiner Vives E
    Int J Clin Pract; 2017 Dec; 71(12):. PubMed ID: 28949430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Home intravenous antibiotic treatment: a study in 515 patients].
    Mendoza-Ruiz de Zuazu H; Casas-Arrate J; Martínez-Martínez C; de la Maza I; Regalado de los Cobos J; Cía-Ruiz JM
    Enferm Infecc Microbiol Clin; 2005; 23(7):396-401. PubMed ID: 16159538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
    Shrestha NK; Mason P; Gordon SM; Neuner E; Nutter B; O'Rourke C; Rehm SJ
    J Antimicrob Chemother; 2014 May; 69(5):1407-15. PubMed ID: 24398341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia.
    Subedi S; Looke DF; McDougall DA; Sehu MM; Playford EG
    Int J Infect Dis; 2015 Jan; 30():161-5. PubMed ID: 25603999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
    Bazaz R; Chapman AL; Winstanley TG
    J Antimicrob Chemother; 2010 Jul; 65(7):1510-3. PubMed ID: 20460397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular access complications during outpatient parenteral antimicrobial therapy at home: a retrospective cohort study.
    Shrestha NK; Shrestha J; Everett A; Carroll D; Gordon SM; Butler RS; Rehm SJ
    J Antimicrob Chemother; 2016 Feb; 71(2):506-12. PubMed ID: 26510718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries.
    Tice A
    Chemotherapy; 2001; 47 Suppl 1():5-16. PubMed ID: 11096184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
    Matthews PC; Conlon CP; Berendt AR; Kayley J; Jefferies L; Atkins BL; Byren I
    J Antimicrob Chemother; 2007 Aug; 60(2):356-62. PubMed ID: 17566002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT).
    Mirón-Rubio M; Parra Jordán JJ; González Ramallo VJ; Mujal Martínez A; Fernández Muixí J; Iglesias Gallego M; Lucas Núñez MC; Rodado Alabau E; Vidal Perez-Campoamor S; Uría E
    Rev Esp Quimioter; 2023 Jun; 36(3):291-301. PubMed ID: 37017118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity.
    Gardiol C; Voumard R; Cochet C; de Vallière S
    Eur J Clin Microbiol Infect Dis; 2016 May; 35(5):839-45. PubMed ID: 26886452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.
    Partridge DG; O'Brien E; Chapman AL
    Postgrad Med J; 2012 Jul; 88(1041):377-81. PubMed ID: 22366395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.